Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type I diabetes mellitus

BMC Immunology

Volumn 4, Issue , 2003, Pages

  Pedotti, Rosetta ^a,b   Sanna, Maija ^a   Tsai, Mindy ^a   DeVoss, Jason ^a   Steinman, Lawrence ^a   McDevitt, Hugh ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MYELIN PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DESIGN; DRUG MECHANISM; FATALITY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREACTIVITY; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL DOCUMENTATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PANCREAS ISLET BETA CELL; RISK BENEFIT ANALYSIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 2542498041     PISSN: 14712172     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2172-4-2     Document Type: Article

References (29)

1. Tisch R and McDevitt H Insulin-dependent diabetes mellitus Cell 1996, 85:291-297
2. Bao M, Yang Y, Jun HS and Yoon JW Molecular mechanisms for gender differences in susceptibility to T cell- mediated autoimmune diabetes in nonobese diabetic mice J Immunol 2002, 168:5369-5375
3. Acha-Orbea H and McDevitt HO The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique Proc Natl Acad Sci U S A 1987, 84:2435-2439
4. Singer SM, Tisch R, Yang XD, Sytwu HK, Liblau R and McDevitt HO Prevention of diabetes in NOD mice by a mutated I-Ab transgene Diabetes 1998, 47:1570-1577
5. Chao CC, Sytwu HK, Chen EL, Toma J and McDevitt HO The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire Proc Natl Acad Sci U S A 1999, 96:9299-9304
6. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, DeCamilli P and Camilli PD Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase Nature 1990, 347:151-156
7. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T and Lernmark A Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type J Clin Invest 1993, 91:368-374
8. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L and McDevitt HO Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice Nature 1993, 366:72-75
9. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ and Lehmann PV Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes Nature 1993, 366:69-72
10. Tisch R, Liblau RS, Yang XD, Liblau P and McDevitt HO Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice Diabetes 1998, 47:894-899
11. Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N and Mitchell D Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein [published erratum appears in Nature 1998 Apr 9;392(6676):630] Nature 1996, 379:343-346
12. Nicholson LB, Greer JM, Sobel RA, Lees MB and Kuchroo VK An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis Immunity 1995, 3:397-405
13. Ruiz PJ, Garren H, Ruiz IU, Hirschberg DL, Nguyen LV, Karpuj MV, Cooper MT, Mitchell DJ, Fathman CG and Steinman L Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation J Immunol 1999, 162:3336-3341
14. Pedotti R, Mitchell D, Wedemeyer J, Karpuj M, Chabas D, Hattab EM, Tsai M, Galli SJ and Steinman L An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide Nat Immunol 2001, 2:216-222
15. Liu E, Moriyama H, Abiru N, Miao D, Yu L, Taylor RM, Finkelman FD and Eisenbarth GS Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23 J Clin Invest 2002, 110:1021-1027
16. Liu FT, Bohn JW, Ferry EL, Yamamoto H, Molinaro CA, Sherman LA, Klinman NP and Katz DH Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization J Immunol 1980, 124:2728-2737
17. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP and Galli SJ Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis J Clin Invest 1997, 99:901-914
18. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK and Geha RS Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice J Clin Invest 1998, 101:1614-1622
19. Hutchings P and Cooke A Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration J Autoimmun 1998, 11:127-1
20. Ramiya VK, Shang XZ, Pharis PG, Wasserfall CH, Stabler TV, Muir AB, Schatz DA and Maclaren NK Antigen based therapies to prevent diabetes in NOD mice J Autoimmun 1996, 9:349-356
21. Williams CM and Galli SJ The diverse potential effector and immunoregulatory roles of mast cells in allergic disease J Allergy Clin Immunol 2000, 105:847-859
22. So T, Ito H, Hirata M, Ueda T and Imoto T Contribution of conformational stability of hen lysozyme to induction of type 2 T-helper immune responses Immunology 2001, 104:259-268
23. Vaysburd M, Lock C and McDevitt H Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides J Exp Med 1995, 182:897-902
24. Derbinski J, Schulte A, Kyewski B and Klein L Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self Nat Immunol 2001, 2:1032-1039
25. Kishimoto H and Sprent J A defect in central tolerance in NOD mice Nat Immunol 2001, 2:1025-1031
26. Lesage S and Goodnow CC Organ-specific autoimmune disease: a deficiency of tolerogenic stimulation J Exp Med 2001, 194:F31-NaN
27. Takai T, Ono M, Hikida M, Ohmori H and Ravetch JV Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice Nature 1996, 379:346-349
28. Ujike A, Ishikawa Y, Ono M, Yuasa T, Yoshino T, Fukumoto M, Ravetch JV and Takai T Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low- affinity Fc receptors for IgG J Exp Med 1999, 189:1573-1579
29. Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P and Steinman L Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group Nat Med 2000, 6:1176-1182